Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 3, 2007, Pages 207-212

  Okamura, Nami ^a   Saito, Maki ^a   Mori, Asami ^a   Sakamoto, Kenji ^a   Kametaka, Sokichi ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FASUDIL; THIOBUTABARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; CAMERA; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EYE FUNDUS; HYPERTENSION; MALE; NONHUMAN; RAT; RETINA ARTERY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SYSTEMIC CIRCULATION; VASODILATATION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNDUS OCULI; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PHOTOGRAPHY; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RETINAL VESSELS; VASODILATION; VASODILATOR AGENTS;

EID: 34250852210     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.128     Document Type: Article

References (33)

1. Kimura, K., Ito, M., Amano, M., et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248, 1996.
2. Narumiya, S. The small GTPase Rho: Cellular functions and signal transduction. J. Biochem. 120:215-228, 1996.
3. Amano, M., Chihara, K., Kimura, K., et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311, 1997.
4. Narumiya, S., Ishizaki, T., Watanabe, N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 410:68-72, 1997.
5. Seasholtz, T.M., Majumdar, M., Kaplan, D.D., et al. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ. Res. 84:1186-1193, 1999.
6. Budzyn, K., Marley, P.D., Sobey, C.G. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol. Sci. 27:97-104, 2006.
7. Uehata, M., Ishizaki, T., Satoh, H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994, 1997.
8. Chrissobolis, S., and Sobey, C.G. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: Comparison with protein kinase C. Circ. Res. 88: 774-779, 2001.
9. Masumoto, A., Hirooka, Y., Shimokawa, H., et al. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38:1307-1310, 2001.
10. Mukai, Y., Shimokawa, H., Matoba, T., et al. Involvement of Rho-kinase in hypertensive vascular disease: A novel therapeutic target in hypertension. FASEB J. 15:1062-1064. 2001.
11. Bhutto, I.A., Amemiya, T. Vascular changes in retinas of spontaneously hypertensive rats demonstrated by corrosion casts. Ophthalmic. Res. 29:12-23, 1997.
12. Bhutto, I.A., and Amemiya, T. Effects of cilazapril on the retinal vessels in spontaneously hypertensive rats: Corrosion cast and scanning electron microscopic study. Life Sci. 64:PL27-PL39. 1999.
13. Dosso, A.A., Leuenberger, P.M., and Rungger-Brandle, E. Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest. Ophthalmol. Vis. Sci. 40:2405-2410, 1999.
14. Hirose, F., Kiryu, J., Miyamoto, K., et al. In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 43:1098-1102, 2004.
15. Tso, M.O., and Jampol, L.M. Pathophysiology of hypertensive retinopathy. Ophthalmology 89:1132-1145, 1982.
16. Tachibana, E., Harada, T., Shibuya, M., et al. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta. Neurochir. 141:13-19, 1999.
17. Bill, A. Blood circulation and fluid dynamics in the eye. Physiol. Rev. 55:383-417, 1975.
18. Bill, A., and Nilsson, S.F. Control of ocular blood flow. J. Cardiovasc. Pharmacol. 3(Suppl. 7):S96-S102, 1985.
19. Harris, A., Ciulla, T.A., Chung, H.S., et al. Regulation of retinal and optic nerve blood flow. Arch. Ophthalmol. 116:1491-1495, 1998.
20. Kaneko, Y., Saito, M., Mori, A., et al. Vasodilator effects of adrenomedullin on retinal arterioles in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther. 22:317-322, 2007.
21. Nakazawa, T., Kaneko, Y., Mori, A., et al. Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vascul. Pharmacol. 46:153-159, 2007.
22. Arnold, J.V., Gates, J.W., and Taylor, K.M. Possible errors in the measurement of retinal lesions. Invest. Ophthalmol. Vis. Sci. 34:2576-2580, 1993.
23. Honjo, M., Inatani, M., Kido, N., et al. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch. Ophthalmol. 119:1171-1178, 2001.
24. Honjo, M., Tanihara, H., Inatani, M., et al. Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42:137-144, 2001.
25. Waki, M., Yoshida, Y., Oka, T., et al. Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr. Eye Res. 22:470-474, 2001.
26. Kitaoka, Y., Kitaoka, Y., Kumai, T., et al. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina. Brain Res. 1018:111-118, 2004.
27. Somlyo, A.P., and Somlyo, A.V. Signal transduction by G-proteins, rho-kinase, and protein phosphatase to smooth muscle and nonmuscle myosin II. J. Physiol. 522:177-185, 2000.
28. Sponsel, W.E., Paris, G., Trigo, Y., et al. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am. J. Ophthalmol. 134:552-559, 2002.
29. Riva, C.E., Sinclair, S.H., and Grunwald, J.E. Autoregulation of retinal circulation in response to decrease of perfusion pressure. Invest. Ophthalmol. Vis. Sci. 21:34-38, 1981.
30. Robinson, F., Riva, C.E., Grunwald, J.E., et al. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest. Ophthalmol. Vis. Sci. 27:722-726, 1986.
31. Asano, T., Ikegaki, I., Satoh, S., et al. Mechanism of action of a novel antivasospasm drug, HA1077. J. Pharmacol. Exp. Ther. 241:1033-1040, 1987.
32. Asano, T., Suzuki, T., Tsuchiya, M., et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br. J. Pharmacol. 98:1091-1100, 1989.
33. 2+ level and contraction in vascular smooth muscle. Eur. J. Pharmacol. 250:431-437, 1993.